Author:
Hoyle Martin,Green Colin,Thompson-Coon Jo,Liu Zulian,Welch Karen,Moxham Tiffany,Stein Ken
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference26 articles.
1. Cancer Statistics Registrations. Registrations of cancer diagnosed in 2004, England. Report No.: Series MB1 no. 35. 2006.
2. WCISU Annual Publication. Cancer Incidence in Wales 2000–2004. Welsh Cancer Intelligence and Surveillance Unit. Report No.: No.SA 6/01. 2006.
3. Thompson-Coon J, Hoyle M, Green C, et al. Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess. In press.
4. Renal Cell Carcinoma – Bevacizumab, Sorafenib, Sunitinib and Temsirolimus: Appraisal Consultation Document;NICE,2008
5. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献